Figure 3

Overall survival in relation to cyclin D1 intensity (low/moderate and high) in (A) all untreated patients, (B) untreated patients with >90% ERα positive cells and (C) tamoxifen treated patients with >90% ERα positive cells. P-values are presented in a box with values at 10 years of follow-up (22 years of follow-up in parenthesis).